David J. Koss

1.7k total citations
37 papers, 1.2k citations indexed

About

David J. Koss is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, David J. Koss has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 14 papers in Cellular and Molecular Neuroscience and 14 papers in Neurology. Recurrent topics in David J. Koss's work include Alzheimer's disease research and treatments (20 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Neuroscience and Neuropharmacology Research (9 papers). David J. Koss is often cited by papers focused on Alzheimer's disease research and treatments (20 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Neuroscience and Neuropharmacology Research (9 papers). David J. Koss collaborates with scholars based in United Kingdom, Germany and United States. David J. Koss's co-authors include Bettina Platt, Tiago F. Outeiro, Gernot Riedel, Johannes Attems, Daniel Erskine, Alan Thomas, Lauren Walker, Ian G. McKeith, Paul C. Donaghy and Christopher M. Morris and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Chemical Communications.

In The Last Decade

David J. Koss

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Koss United Kingdom 18 652 368 311 307 227 37 1.2k
Matthew Kirkcaldie Australia 16 362 0.6× 272 0.7× 331 1.1× 310 1.0× 262 1.2× 34 1.1k
David H. Adamowicz United States 7 938 1.4× 229 0.6× 465 1.5× 463 1.5× 392 1.7× 10 1.4k
Daniel Erskine United Kingdom 20 604 0.9× 758 2.1× 262 0.8× 312 1.0× 338 1.5× 47 1.4k
Jennifer L. Furman United States 13 880 1.3× 276 0.8× 364 1.2× 535 1.7× 479 2.1× 15 1.5k
Thomas G. Beach Canada 18 702 1.1× 282 0.8× 532 1.7× 494 1.6× 402 1.8× 39 1.6k
Scarlett J. Barker United States 5 705 1.1× 189 0.5× 444 1.4× 542 1.8× 400 1.8× 5 1.4k
Yun Ha Jeong South Korea 15 450 0.7× 423 1.1× 248 0.8× 444 1.4× 258 1.1× 24 1.3k
Helen Y. Figueroa United States 14 1.1k 1.7× 255 0.7× 554 1.8× 548 1.8× 379 1.7× 16 1.7k
Heather McCann Australia 23 811 1.2× 1.1k 2.9× 520 1.7× 438 1.4× 410 1.8× 39 2.0k
Mark Frasier United States 15 448 0.7× 1.0k 2.8× 449 1.4× 379 1.2× 264 1.2× 28 1.5k

Countries citing papers authored by David J. Koss

Since Specialization
Citations

This map shows the geographic impact of David J. Koss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Koss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Koss more than expected).

Fields of papers citing papers by David J. Koss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Koss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Koss. The network helps show where David J. Koss may publish in the future.

Co-authorship network of co-authors of David J. Koss

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Koss. A scholar is included among the top collaborators of David J. Koss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Koss. David J. Koss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koss, David J., et al.. (2025). Nuclear Alpha‐Synuclein: Mechanisms and Implications for Synucleinopathies. Movement Disorders. 41(3). 603–612.
2.
Koss, David J., L. Findlay, Paweł Palmowski, et al.. (2025). A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies. Molecular Neurodegeneration. 20(1). 34–34. 2 indexed citations
3.
Galgani, Alessandro, Kirsty E. McAleese, Lauren Walker, et al.. (2024). Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica. 147(1). 40–40. 2 indexed citations
4.
Koss, David J., et al.. (2022). Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications. 10(1). 98–98. 43 indexed citations
5.
McAleese, Kirsty E., Mohi Miah, Sophie Graham, et al.. (2021). Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathologica. 142(6). 937–950. 56 indexed citations
6.
Erskine, Daniel, David J. Koss, Viktor I. Korolchuk, et al.. (2021). Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders. Acta Neuropathologica. 141(4). 511–526. 38 indexed citations
7.
8.
Outeiro, Tiago F., David J. Koss, Daniel Erskine, et al.. (2019). Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration. 14(1). 5–5. 242 indexed citations
9.
Szegő, Éva M., Antonio Dominguez‐Meijide, Ellen Gerhardt, et al.. (2019). Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies. Cell Reports. 28(1). 65–77.e6. 44 indexed citations
10.
Mietelska‐Porowska, Anna, Anna Gąsiorowska, Ewelina Pałasz, et al.. (2018). Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride. Journal of Neuroscience Methods. 319. 47–59. 4 indexed citations
11.
Koss, David J., et al.. (2016). Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline. Acta Neuropathologica. 132(6). 875–895. 102 indexed citations
12.
Plucińska, Kaja, David J. Koss, Kirsty Shearer, et al.. (2016). Neuronal human BACE1 knockin induces systemic diabetes in mice. Diabetologia. 59(7). 1513–1523. 54 indexed citations
13.
Koss, David J., Lianne Robinson, Benjamin D. Drever, et al.. (2016). Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology. Neurobiology of Disease. 91. 105–123. 57 indexed citations
14.
Koss, David J., Lianne Robinson, Anna Mietelska‐Porowska, et al.. (2015). Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits. Cellular and Molecular Life Sciences. 72(23). 4613–4632. 7 indexed citations
15.
Koss, David J., Benjamin D. Drever, Sandra Stoppelkamp, Gernot Riedel, & Bettina Platt. (2013). Age-dependent changes in hippocampal synaptic transmission and plasticity in the PLB1Triple Alzheimer mouse. Cellular and Molecular Life Sciences. 70(14). 2585–2601. 20 indexed citations
16.
Koss, David J., Gernot Riedel, Kendra K. Bence, & Bettina Platt. (2012). Store-operated Ca2+ entry in hippocampal neurons: Regulation by protein tyrosine phosphatase PTP1B. Cell Calcium. 53(2). 125–138. 20 indexed citations
17.
Dall’Angelo, Sergio, David J. Koss, Juozas Domarkas, et al.. (2012). 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease. Chemical Communications. 49(8). 792–794. 7 indexed citations
18.
Platt, Bettina, Benjamin D. Drever, David J. Koss, et al.. (2011). Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1. PLoS ONE. 6(11). e27068–e27068. 110 indexed citations
19.
Koss, David J., Gernot Riedel, & Bettina Platt. (2009). Intracellular Ca2+ stores modulate SOCCs and NMDA receptors via tyrosine kinases in rat hippocampal neurons. Cell Calcium. 46(1). 39–48. 19 indexed citations
20.
Koss, David J., et al.. (2007). Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases. Journal of Neurochemistry. 102(4). 1009–1023. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Kirkcaldie Breakdown of academic impact, for papers by David H. Adamowicz Breakdown of academic impact, for papers by Daniel Erskine Breakdown of academic impact, for papers by Jennifer L. Furman Breakdown of academic impact, for papers by Thomas G. Beach Breakdown of academic impact, for papers by Scarlett J. Barker Breakdown of academic impact, for papers by Yun Ha Jeong Breakdown of academic impact, for papers by Helen Y. Figueroa Breakdown of academic impact, for papers by Heather McCann Breakdown of academic impact, for papers by Mark Frasier
Rankless by CCL
2026